Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5526_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
29 Мб
Скачать
31 Headache Attributed toLow Cerebrospinal Fluid (CSF) Pressure
Fig. 31.5 Dynamic CT myelography showing delayed washout contrast in the left intervertebral venous plexus
297
Fig. 31.6 Dynamic CT myelography showing contrast showing CVF at the level of T10-T11
298
M. N. P. Souza and D. G. L. Edelmuth
Once the diagnosis of CSF–venous stula was conrmed, the patient underwent transvenous embolization (Fig.31.7).
He showed progressive improvement, with complete clinical recovery after two weeks. A control brain MRI demonstrated improvement in SIH signs and complete resolution of the subdural hematomas (Fig.31.8).
Fig. 31.7 CVF embolization with Onyx
ab
Fig. 31.8 Post-treatment brain MRI. (a) Axial T1-weighted image showing resolution of the sub­dural collection. (b) Sagittal T1-weighted image showing resolution of brain sagging
31 Headache Attributed toLow Cerebrospinal Fluid (CSF) Pressure
299

31.4 Case Discussion

This case demonstrated a typical presentation of SIH, with new-onset daily ortho­static headache. The patient’s advanced age and comorbidities increased the com­plexity of management, and the worsening of the subdural hematoma represented a life-threatening complication that was successfully treated. An important insight from this case is that not all SIH patients present with spinal longitudinal epidural collection (SLEC), which is particularly true for virtually all cases of CSF–venous stula. Adding further complexity, the rst dynamic lateral decubitus CT myelogra­phy did not show the stula. However, considering the specicity of the clinical and radiological presentation, the care team decided to repeat the exam, switching the decubitus side. This decision proved crucial to identifying the CSF–venous stula. After successful embolization, the patient showed complete clinical and radiologi­cal improvement. The case highlights the importance of managing complex cases of SIH in specialized centers, where patients may have access to well-trained, multi­disciplinary teams that can improve diagnostic accuracy and prognosis.

31.5 Clinical Presentation

Orthostatic headache is the most common symptom of SIH, being present in 75–97% of patients [5, 6]. However, the duration of symptoms may change the typi­cal orthostatic presentation. In one study, over 93% of patients evaluated with <10weeks since the beginning of symptoms presented with orthostatic headache, whereas it was present in only 62.5% of those who were evaluated with >10weeks [7]. Other common signs and symptoms are nausea, neck pain or stiffness, hearing disturbances, dizziness, and tinnitus [5]. Other rare presentations include movement disorders, nonorthostatic headache, and cognitive symptoms mimicking frontotem­poral dementia [5].
Patients with SIH may also present acute and chronic complications. The most frequent acute complication is subdural hematoma, which is present in up to 40% of patients, and usually is laminar, but occasionally may have high volume and require urgent intervention [5]. More rarely, patients with SIH may be complicated by cere­bral venous thrombosis [6]. Chronic complications include supercial siderosis and brachial amyotrophy [8].
31.6 Diagnosis andTreatment
The diagnosis of SIH may be simple in cases with typical presentation, but it often presents challenges that may be related to atypical presentations, most commonly the absence of a clear orthostatic headache, and to difculties in accessing adequate
300
M. N. P. Souza and D. G. L. Edelmuth
investigation. Therefore, it has appropriately been proposed that the diagnostic rationale must consider the context of healthcare delivery. In this context, we pro­pose a diagnostic algorithm that considers both non-specialized and specialized centers [9].
For all patients presenting with clinical suspicion, brain MRI with contrast should be considered. The diagnosis is conrmed by signs of SIH in the brain MRI or by documented low CSF pressure (< 60mm CSF) [10, 11]. The most common signs of SIH on brain MRI are diffuse pachymeningeal enhancement, intracranial venous engorgement, enlarged pituitary gland, subdural collection, and brain sag­ging [5]. Other ndings may include effacement of the suprasellar cistern, reduction in the prepontine cistern, and decreased mamillopontine distance [12].
Conservative treatment consists of bed rest, hydration (2–2.5L/day), and avoid­ance of Valsalva maneuvers. Although ineffective in over 75% of patients with SIH, it is considered the rst-line option for those within two weeks of symptom onset [5, 9].
Epidural blood patch (EBP) consists of the injection of autologous blood in the epidural space. It is widely considered the rst choice of treatment in patients who have a diagnosis of SIH and have an unavailable spine MRI.A non-targeted blood patch consists of any EBP that is performed without an invasive myelography to conrm the precise leak site. Several studies have shown that a non-targeted blood patch may be successful for up to 67% of patients [5]. In non-specialized centers, for patients who have no or sub-optimal improvement, a second EBP should be considered [9]. High-volume EBP ( 20mL) has higher rates of success [5].
Spine MRI is increasingly considered necessary as an initial step in the investiga­tion of SIH, when available [3]. The presence of a spinal longitudinal epidural col­lection (SLEC) suggests that the etiology is either a CSF leak from a nerve root sleeve diverticulum or an osteophyte spur. In such cases, epidural blood patching (targeted or non-targeted) and surgery should be considered, depending on the clini­cal context and local availability. When spine MRI shows no signs of SLEC, a CVF should be suspected, and patients should be referred to specialized centers for fur­ther evaluation with either dynamic lateral decubitus CT myelography (DL-CTM) or digital subtraction myelography (DSM) [9]. Once the CVF is documented, treat­ment options include surgery and intravascular embolization.
31 Headache Attributed toLow Cerebrospinal Fluid (CSF) Pressure
Algorithm
Non-specialized Center
301
302
Specialized Center

31.7 Conclusion

M. N. P. Souza and D. G. L. Edelmuth
Spontaneous intracranial hypotension (SIH) is an increasingly recognized cause of secondary headache, with orthostatic headache being its most characteristic feature. Early recognition is crucial to prevent potentially severe complications, such as sub­dural hematomas, and to guide appropriate investigation. This chapter has outlined the pathophysiology, clinical presentation, diagnostic approach, and treatment strat­egies for SIH, illustrated by a complex case involving a CSF–venous stula. The case reinforces the importance of specialized centers and advanced imaging tech­niques in achieving an accurate diagnosis, particularly in atypical or refractory pre­sentations. Insights from recent advances in the understanding of SIH highlight the evolving landscape of management, underscoring the need for individualized and multidisciplinary care approaches to improve patient outcomes.

References

1. Amrhein TJ, Kranz PG. Spontaneous intracranial hypotension: imaging in diagnosis and treatment. Radiol Clin North Am. 2019;57:439–51. Elsevier Inc. https://doi.org/10.1016/j.
rcl.2018.10.004.
2. Kranz PG, Tanpitukpongse TP, Choudhury KR, Amrhein TJ, Gray L.How common is nor­mal cerebrospinal uid pressure in spontaneous intracranial hypotension? Cephalalgia. 2016;36(13):1209–17.
31 Headache Attributed toLow Cerebrospinal Fluid (CSF) Pressure
3. Farnsworth PJ, Madhavan AA, Verdoorn JT, Shlapak DP, Johnson DR, Cutsforth-Gregory JK, Brinjikji W, Lehman VT. Spontaneous intracranial hypotension: updates from diagnosis to treatment. Neuroradiology. 2023;65(2):233–43.
4. Schievink WI, Schwartz MS, Maya MM, Moser FG, Rozen TD. Lack of causal asso­ciation between spontaneous intracranial hypotension and cranial cerebrospinal uid leaks. J Neurosurg. 2012;116(4):749–54. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/22264184.
5. D'Antona L, Jaime Merchan MA, Vassiliou A, Watkins LD, Davagnanam I, Toma AK, Matharu MS.Clinical presentation, investigation ndings, and treatment outcomes of spon­taneous intracranial hypotension syndrome: a systematic review and meta-analysis. JAMA Neurol. 2021;78(3):329–37. https://doi.org/10.1001/jamaneurol.2020.4799.
6. Mehta D, Cheema S, Glover S, Qureshi AM, Davagnanam I, Kamourieh S, Sayal P, Toma A, Lagrata S, Joy C, Duncan C, Anderson J, Davies B, Dorman PJ, Angus-Leppan H, Walkden J, Rohrer J, Matharu MS.Dening the typical characteristics of orthostatic headache in patients with spontaneous intracranial hypotension. Cephalalgia. 2025;45(1):3331024241308154.
https://doi.org/10.1177/03331024241308154.
7. Häni L, Fung C, Jesse CM, Ulrich CT, Miesbach T, Cipriani DR, Dobrocky T, Z'Graggen WJ, Raabe A, Piechowiak EI, Beck J.Insights into the natural history of spontaneous intracranial hypotension from infusion testing. Neurology. 2020;95(3):e247–55. https://doi.org/10.1212/
WNL.0000000000009812.
8. Schievink WI, Maya M, Moser F, Nuño M. Long-term risks of persistent ventral spi­nal CSF leaks in SIH: supercial Siderosis and Bibrachial Amyotrophy. Neurology. 2021;97(19):E1964–70.
9. Cheema S, Anderson J, Angus-Leppan H, Armstrong P, Butteriss D, Carlton Jones L, Choi D, Chotai A, D'Antona L, Davagnanam I, Davies B, Dorman PJ, Duncan C, Ellis S, Iodice V, Joy C, Lagrata S, Mead S, Morland D, Nissen J, Pople J, Redfern N, Sayal PP, Scofngs D, Secker R, Toma AK, Trevarthen T, Walkden J, Beck J, Kranz PG, Schievink W, Wang SJ, Matharu MS.Multidisciplinary consensus guideline for the diagnosis and management of spontane­ous intracranial hypotension. J Neurol Neurosurg Psychiatry. 2023;94(10):835–43. https://doi.
org/10.1136/jnnp- 2023- 331166.
10. Schievink WI, Ropper AH, editors. Spontaneous Intracranial Hypotension. N Engl J Med. 2021;385(23):2173–8. Available from: http://www.nejm.org/doi/10.1056/NEJMra2101561.
11. Olesen J, Headache Classication Committee of the International Headache Society (IHS). The international classication of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. Available from: http://journals.sagepub.com/doi/10.1177/0333102417738202.
12. Dobrocky T, Grunder L, Breiding PS, Branca M, Limacher A, Mosimann PJ, Mordasini P, Zibold F, Haeni L, Jesse CM, Fung C, Raabe A, Ulrich CT, Gralla J, Beck J, Piechowiak EI.Assessing spinal cerebrospinal uid leaks in spontaneous intracranial hypotension with a scoring system based on brain magnetic resonance imaging ndings. JAMA Neurol. 2019;76(5):580–7. https://doi.org/10.1001/jamaneurol.2018.4921.
https://doi.org/10.1007/s00234- 022- 03079- 5.
303
Chapter 32
Headache Attributed toNeurosarcoidosis
MohamadAliHussein , MarcoAntonioNihi , andCamilaCarneiroFerreira

32.1 Introduction

Sarcoidosis is an immune-mediated disorder characterized by granulomatous inammation of affected organs [1]. Neurological involvement of sarcoidosis (neu­rosarcoidosis) can involve the central nervous system or peripheral nervous system. Meningitis accounts for 10–20% of cases of neurosarcoidosis [2], which may or may not be associated with other types of involvement, such as cranial neuropathy (50–75%), myelopathy (5–26%), and peripheral neuropathy (2–86%) [3]. In lepto­meningeal presentation, patients typically present with subacute to chronic onset of headache, constitutional symptoms, and signs of meningeal irritation [4]. By explor­ing the nuances of headaches attributed to neurosarcoidosis, this chapter aims to elucidate the implications of these ndings for clinical practice and future investiga­tions, providing a comprehensive overview of the challenges and potential strate­gies for managing this complex condition.

32.2 Pathophysiology

The International Classication of Headache Disorders, third edition (ICHD-3) classies the headache related to neurosarcoidosis as headache attributed to nonin­fectious inammatory Diseases and it may result from several pathophysiological mechanisms, depending on the neurological structures involved by granulomatous severity, such as granulomatous meningitis, intracranial hypertension, hydrocepha­lus, central neuropathic pain, and headache secondary to use of corticosteroids.
M. A. Hussein (*) · M. A. Nihi · C. C. Ferreira Neurological Institute of Neurology of Curitiba, Curitiba, Brazil
Switzerland AG 2026 D. Uludüz et al. (eds.), Rare Causes of Headache Disorders, Headache,
https://doi.org/10.1007/978-3-032-10242-3_32
305© The Author(s), under exclusive license to Springer Nature
306
M. A. Hussein et al.
Neurosarcoidosis is an essential cause of noninfectious meningitis, especially drug-induced aseptic meningitis [5]. The major causative agents are nonsteroidal anti-inammatory drugs (NSAIDs), antimicrobials, intravenous immunoglobulin, intrathecal agents, vaccines, and several other less frequently reported agents. One of the pathophysiological hypotheses is related to immunological mechanisms with hypersensitivity reaction, since the symptoms begin quickly after the medication ingestion. This can be explained through the hapten theory, in which a drug could act as a hapten that binds to intravascular proteins, prompting the immune system to subsequently recognize those proteins as foreign antigens [6].
In cases of intracranial hypertension, headache may be explained by parenchy­mal edema, increased cerebral blood volume, excessive cerebrospinal uid (CSF) production, compromised cerebrospinal uid reabsorption, and venous outow obstruction [6]. There are also several other hypotheses to explain the pathophysi­ological mechanisms of headaches in patients diagnosed with neurosarcoidosis, such as those attributed to lymphocytic hypophysitis, intracranial neoplasm, epilep­tic seizures, and Chiari malformations type I.However, there is still a lack of studies that can explain the real mechanism of this condition.

32.3 Case Presentation

Ucb, a 38-year-old woman, presented with a history of a subacute onset of migraine­pattern headache, characterized by pulsating pain of high intensity, associated with nausea and photophobia, without aura symptoms. Initially, the pain lasted from hours to days, but it progressed to chronicity, with daily headaches. In addition to the headache, the patient reported worsening vertigo and gait ataxia that had been progressively deteriorating. During the rst few months, she attended several emer­gency departments, being treated for a diagnosis of migraine. When the episodes began to exhibit signs and symptoms of cerebellar origin vertigo, such as multidi­rectional and non-fatigable nystagmus, axial ataxia, and accentuated limb ataxia, the patient underwent further investigation with a magnetic resonance imaging (MRI) of the brain, which revealed leptomeningeal enhancement in the brainstem and cerebellum (see Fig.32.1). Extending the investigation with MRI of the spinal column also showed altered contrast enhancement at the cervical spinal cord level (see Fig.32.1). A lumbar puncture was performed, revealing pleocytosis (93 cells) with a predominance of lymphomonocytic cells, as well as an increase in protein content in the sample (223g/L). Following a hypothesis of granulomatous disease, screening for other systemic inammatory foci was conducted, which returned neg­ative. This led to a meningeal biopsy, which, in addition to the clinical ndings, conrmed the diagnosis of neurosarcoidosis, as it found non-necrotizing granulo­mas, with no other foci of systemic disease identied.
After treatment with pulsotherapy, with methylprednisolone, the patient exhib­ited symptomatic improvement, maintaining the same imaging pattern for several months, until a reduction in contrast uptake in the leptomeninges was observed. She
32 Headache Attributed toNeurosarcoidosis
307
Fig. 32.1 MRI ndings of our case show cerebellar leptomeningeal enhancement, in the brain­stem and in the cervical spinal cord
initiated treatment with methotrexate, achieving satisfactory disease control, with only one relapse during follow-up so far, also treated with pulsotherapy, with no signicant sequelae remaining.

32.4 Case Discussion

The presented case illustrates a phenotypic manifestation of leptomeningitis in a case of neurosarcoidosis without systemic involvement. The inammatory nature of the disease leads to a clinical presentation characterized by relapses, which typically respond well to corticosteroid treatment. Neurosarcoidosis is a rare disease with a broad phenotypic spectrum; for this reason and others, there is still no consensus on the best approach to monitor and treat these patients. The case presented exemplies